Family Medicine | Page 185 of 374 | Links Medicus Content Curation & Alerts in Medicine

Global burden of cardiovascular diseases and risk factors, 1990–2019

10 Dec, 2020 | 09:00h | UTC

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study – Journal of the American College of Cardiology

News Release: JACC: Cardiovascular Disease Burden, Deaths Are Rising Around the World – Institute for Health Metrics and Evaluation

Commentary on Twitter

https://twitter.com/IHME_UW/status/1336792746842058756

Systematic Review: Probiotics probably make little or no difference for patients with acute infectious diarrhea

10 Dec, 2020 | 08:53h | UTC

Probiotics for treating acute infectious diarrhoea – Cochrane Library

Summary: Do probiotics help to treat acute infectious diarrhoea? – Cochrane Library

Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death

10 Dec, 2020 | 08:45h | UTC

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission – Nature Medicine

Commentary: Men face ‘almost three times the odds’ of ICU admission for Covid-19, study says – CNN AND Men with COVID-19 three times more likely to need intensive care: study – MedicalXpress

Commentary on Twitter

Men w/ COVID19 are 3 times more likely to need intensive care & are at significantly higher risk of dying from the virus than women. New research analyzed over 3 million confirmed cases from 46 countries and 44 states. 2 links: https://t.co/g9nYKWxzcv
andhttps://t.co/ZOIfSYImWi

— delthia ricks 🔬 (@DelthiaRicks) December 9, 2020

Randomized trial: In patients with recurrent, complicated, or persistent painful diverticulitis, sigmoid resection improved quality of life but was associated with a small but significant risk of major complications

10 Dec, 2020 | 08:51h | UTC

Comparing Laparoscopic Elective Sigmoid Resection With Conservative Treatment in Improving Quality of Life of Patients With Diverticulitis: The Laparoscopic Elective Sigmoid Resection Following Diverticulitis (LASER) Randomized Clinical Trial – JAMA Surgery

Author Interview: Laparoscopic Sigmoid Resection vs Conservative Treatment in Improving Quality of Life in Diverticulitis

Commentary: Laparoscopic sigmoid resection for recurrent diverticulitis associated with higher quality of life scores – 2 Minute Medicine

Commentary on Twitter

https://twitter.com/drferzli/status/1330948905941557248

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions

10 Dec, 2020 | 08:41h | UTC

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions – Reuters

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

9 Dec, 2020 | 08:23h | UTC

CDC Releases New Ventilation Guidelines For Indoor Environments To Reduce Covid-19 Risk – Forbes

CDC Guideline: Ventilation

Vast majority of pregnant women with COVID-19 won’t have complications, study finds

10 Dec, 2020 | 08:39h | UTC

Vast Majority of Pregnant Women with COVID-19 Won’t Have Complications, Study Finds – NIH Director’s Blog

Original study: Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection – JAMA Network Open

Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen

9 Dec, 2020 | 08:25h | UTC

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet

Commentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT AND Oxford–AstraZeneca COVID-19 vaccine efficacy – The Lancet AND Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials – The Lancet AND Expert reaction to a study on the results of phase 3 human trials of the Oxford/AZ COVID-19 vaccine – Science Media Centre

“COVID-19: when are you most infectious?” This commentary from the authors of a recent meta-analysis highlights the findings that infectiousness peaks within the first 5 days of symptom onset

10 Dec, 2020 | 08:38h | UTC

COVID-19: when are you most infectious? – The Conversation

Original study and commentaries: Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset

Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19

9 Dec, 2020 | 08:19h | UTC

Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial – Annals of Internal Medicine

Summary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection

Randomized trial: No benefit and potential harm from Vitamin D at doses of 1000 IU/d or higher compared with 200 IU/d in older persons with elevated fall risk

9 Dec, 2020 | 08:13h | UTC

The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults: A Response-Adaptive, Randomized Clinical Trial – Annals of Internal Medicine

Commentaries: Study Finds No Benefit, Possible Harm to Seniors’ Fall Risks with Higher Doses of Vitamin D – Johns Hopkins Medicine AND Does High-Dose Vitamin D Actually Heighten Fall Risk? – Physician’s Weekly

Commentary on Twitter (thread – click for more)

https://twitter.com/ErinMichos/status/1336091776994537472

Cohort study: In the general population, both low and high levels of LDL cholesterol were associated with an increased risk of all-cause mortality

9 Dec, 2020 | 08:11h | UTC

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study – The BMJ

Commentary on Twitter

Studies on the association between LDL-C levels and the risk of all cause mortality have provided conflicting results. This new study investigates the association between levels of LDL-C and the risk of all cause and cause specific mortalityhttps://t.co/phsKXIgPfq

— The BMJ (@bmj_latest) December 8, 2020

If exposed to Covid-19, how long before you have symptoms? Median incubation is 5.1 days, and 97.5% of those who develop symptoms do so within 11.5 days of being exposed to the virus

8 Dec, 2020 | 08:06h | UTC

If Exposed To Covid-19 Coronavirus, How Long Before You Have Symptoms – Forbes

Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines

8 Dec, 2020 | 07:55h | UTC

Get Ready for False Side Effects – Science Translational Medicine

First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?”

8 Dec, 2020 | 07:46h | UTC

First-of-its-kind African trial tests common drugs to prevent severe COVID-19 – Science

Observational study: Even low dose oral glucocorticoids linked to increased cardiovascular risk in people with immune-mediated inflammatory diseases

8 Dec, 2020 | 07:35h | UTC

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study – PLOS Medicine

Commentary: Patients receiving low dose steroid at increased risk of cardiovascular disease – Public Library of Science

Randomized trial: In pregnant women with mild and moderate chronic hypertension, the use of labetalol was associated with more adverse events compared to methyldopa or no medication

8 Dec, 2020 | 07:26h | UTC

Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Hypertension in Pregnancy

Commentary: Methyldopa versus labetalol or no medication for the treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Physician’s Weekly

New CDC Guidance with 10 public health strategies to address high levels of community transmission of SARS-Cov-2, including universal use of face masks

7 Dec, 2020 | 01:10h | UTC

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Masks are critical to stopping coronavirus spread, even at home, CDC says – CNN AND CDC recommends ‘universal’ use of face masks to prevent COVID-19 spread – UPI

Commentary on Twitter

In most of the US, Covid transmission is at dangerously high levels. CDC released a new package of 10 key strategies needed to curb the spread, including universal masking and postponing travel. https://t.co/b0utHmygSI pic.twitter.com/HXjlo89WrR

— Dr. Tom Frieden (@DrTomFrieden) December 5, 2020

Spironolactone use is associated with improved outcomes in patients with heart failure with preserved ejection fraction and concomitant resistant hypertension

8 Dec, 2020 | 07:44h | UTC

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension – Journal of the American Heart Association

Commentary: Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension – 2 Minute Medicine

Meta-analysis: Respiratory function post-infection by COVID-19. Altered diffusion capacity, restrictive pattern, and obstructive pattern were found in 39%, 15% and 7% of patients, respectively

7 Dec, 2020 | 01:04h | UTC

Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis – Pulmonology

Commentary on Twitter

Check out our recent systematic review in post-COVID-19 patients. Altered diffusion capacity, restrictive pattern and obstructive pattern were found in 39%, 15% and 7% of patients, respectively. @VilaroJordi @lvasconcello @RestoyAlsina @BufadorBufador https://t.co/PDHcUOCEbw

— Rodrigo Torres Castro (@klgorodtorres) November 25, 2020

Study in Germany comparing regions with vs. without mask mandates concluded that 20 d after becoming mandatory, face masks reduced new Covid-19 infections by around 45%

7 Dec, 2020 | 00:46h | UTC

Face masks considerably reduce COVID-19 cases in Germany – Proceedings of the National Academy of Sciences

Case-control study: Meningococcus B vaccine prevents disease with 79 percent effectiveness in children and young adults

6 Dec, 2020 | 23:48h | UTC

Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal – JAMA

Commentary: Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s – University of Bristol

Commentary on Twitter

In this matched case-control study, children who developed meningococcal disease were less likely to have been vaccinated with 4CMenB vs matched controls without meningococcal disease during the first 5y of vaccine availability in Portugal https://t.co/dGagZ3aTIB @adamhfinn

— JAMA (@JAMA_current) December 3, 2020

Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients

7 Dec, 2020 | 00:44h | UTC

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial – JAMA

Editorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease

Commentary: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases

Commentary on Twitter

In patients w high-risk CVD, high-dose trivalent influenza vaccine, vs standard-dose quadrivalent vaccine, did not significantly reduce all-cause mortality or cardiopulmonary hospitalizations https://t.co/I3XygBajQL

— JAMA (@JAMA_current) December 4, 2020